Clinical trial
Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy
NCT04882592 is registered in ClinicalTrials.gov with SpineX Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy
- Lead sponsor
- SpineX Inc.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- May 15, 2021
- Completion date
- December 1, 2024
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.